Acorda Therapeutics, Inc.
ACORDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001008848
Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Acorda Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 34 | 34 | 0 |
| Shares | 3.97M | 3.37M | −598.0K (−15.1%) |
| Value | $9.48M | $5.42M | −$4.06M (−42.8%) |
New holders (4)
Institutions that held Acorda Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 13,505 | $22.0K | 0.00% |
| Citigroup Inc | 1,658 | $3.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 579 | $1.00K | 0.00% |
| Capital Advisors, Ltd. LLC | 37 | $0 | 0.00% |
Sold out (4)
Institutions that held Acorda Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Highbridge Capital Management LLC | 282,193 | $674.0K |
| Invesco Ltd. | 77,868 | $186.0K |
| Blair William & Co | 23,840 | $57.0K |
| Citadel Advisors LLC | 14,455 | $35.0K |